Brandywine Global Investment Management, LLC Actinium Pharmaceuticals, Inc. Transaction History
Brandywine Global Investment Management, LLC
- $13 Billion
- Q2 2024
A detailed history of Brandywine Global Investment Management, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 128,200 shares of ATNM stock, worth $230,760. This represents 0.01% of its overall portfolio holdings.
Number of Shares
128,200
Previous 145,600
11.95%
Holding current value
$230,760
Previous $1.14 Million
16.84%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ATNM
# of Institutions
76Shares Held
7.05MCall Options Held
96.6KPut Options Held
70.5K-
Black Rock Inc. New York, NY1.88MShares$3.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$2.66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$1.2 Million0.0% of portfolio
-
State Street Corp Boston, MA610KShares$1.1 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0256KShares$460,8460.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $45.3M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...